Protamine sulfate reduces postoperative compression time after dTRA coronary angiography

Announcing a new article publication for Cardiovascular Innovations and Applications journal. With distal transradial access (dTRA), the postoperative compression time remains significantly longer than the recommended range via in practice. This study investigates whether intravenous protamine sulfate might shorten the postoperative compression time and increase safety after coronary angiography via dTRA.

In this retrospective study, patients who underwent coronary angiography were enrolled and divided into two groups. The study group received a slow intravenous injection of 15-20 mg protamine sulfate before sheath retraction. The primary endpoint was the puncture compression time after coronary angiography.
A total of 97 patients in the protamine group and 293 in the control group were enrolled. Intraoperative heparin use, contrast dose, angiography duration, and radiation dose did not differ significantly between groups.

The mean compression time in the control group was 2.9 ± 0.5 hours, whereas that in the protamine group was 1.6 ± 0.9 hours (P < 0.001). No significant difference was observed in postoperative minor or major hemorrhage or hematoma between groups. Ultrasound 24 hours after angiography indicated an incidence of radial artery thrombosis of 1.1% in the control group and 4.3% in the protamine treatment group, with no statistically significant difference between groups (P = 0.209), and no radial artery occlusion in either group.

Logistic regression suggested that radial artery thrombosis was associated with intraoperative heparin dose and a history of chronic kidney disease.

Intravenous application of protamine after coronary angiography via dTRA can significantly shorten the time of postoperative compression hemostasis and has good performance in terms of safety.

Source:
Journal reference:

Liu, M., et al. (2025) Intravenous Protamine Sulfate Shortens Compression Time After Coronary Angiography via Distal Transradial Access. Cardiovascular Innovations and Applications. doi.org/10.15212/CVIA.2024.0062.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Coronary atherosclerosis prevalent even in low-risk adults with normal cholesterol levels